Need more AMR surveillance studies or build your own AMR map? Check out AMRcloud

Russian Version

AMRmap (AntiMicrobial Resistance Map) is a web platform for analysis of AMR data in Russia that contains a set of tools to visualize the data on distribution of antimicrobial susceptibilities and main genetic resistance determinants in clinical microbial isolates.
Citation: Kuzmenkov AY, Trushin IV, Vinogradova AG, Avramenko AA, Sukhorukova MV, Malhotra-Kumar S, Dekhnich AV, Edelstein MV, Kozlov RS (2021). AMRmap: an interactive web platform for analysis of antimicrobial resistance surveillance data in Russia. Front. Microbiol. 12:620002. doi: 10.3389/fmicb.2021.620002
The AMRmap database accumulates the data from prospective multicenter AMR surveillance studies conducted by the Institute of Antimicrobial Chemotherapy (IAC) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC). Currently, the database contains information on susceptibilities of >40,000 clinical microbial isolates collected in 52 cities of Russia in 1997-2016 and tested at central laboratory of IAC.
The data on antibiotic resistance phenotypes and genotypes of Neisseria gonorrhoeae are accumulated from surveillance studies conducted by the State Research Center of Dermatovenereology and Cosmetology.
Susceptibility categories to antimicrobial agents are determined according to current EUCAST Clinical Breakpoints and Russian National Clinical Recommendations on AST.




For some antibiotics, S/I/R categorization data can be limited only to those species within the group for which the clinical breakpoints are currently established





Save map

Press 'Display' each time you change the parameters

The number in each cell indicates the percentage of isolates that are resistant to antibiotic in a column, of the total number of isolates that are resistant to antibiotic in a row.

The trend reflects the proportion of isolates resistant to antibiotic 2 from the total number of isolates that are resistant to antibiotic 1.

The table shows the number and percent of isolates resistant to antibiotic 2 of the total number of isolates resistant to antibiotic 1.

Prevalence of isolates simultaneously resistant to selected antibiotics


The antibiotic resistance (R) rules are searched for from the actual data set and selected parameters using a heuristic algorithm. The searching algorithm does not take into account any predefined rules (e.g. species-specific intrinsic resistance).



Save map

This tab shows the total number of isolates carrying specific markers annually collected as part of prospective surveillance as well as isolates referred to the central laboratory for identification or confirmation of particular resistance genotypes. Analysis of isolates collected in 2018-2018 is in progress.

This tab shows the annual prevalence of resistance markers among consecutive isolates collected as part of prospective surveillance. Analysis of isolates collected in 2018-2019 is in progress.

According to data from surveillance studies.


p-value is rounded to 4 digits after decimal point



Team

Developers

Alexey Yu. Kuzmenkov, MD, PhD — Author and Lead Developer
Deputy Director, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
Ivan V. Trushin — Developer
Research associate, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
Andrey A. Avramenko — Developer
Research associate, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
Alina G. Vinogradova — Developer
Research associate, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)

Consultants

Roman S. Kozlov, MD, MSc, DSc
Corresponding Member of the Russian Academy of Sciences (RAS)
Andrey V. Dehnich, MD, MSc, PhD
Deputy Director, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
Mikhail V. Edelstein, PhD
Head, Laboratory of Antimicrobial Resistance, Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU)
О проекте

logo About the Project

AMRmap Version

2.1, 14.04.2020

Last Update

01.04.2021

Coordinating organizations

  • Inter-regional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC).
  • Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU).

Contacts

Alexey Yu. Kuzmenkov

Publications

ePoster ECCMID 2017

The rates of mutations associated with macrolide resistance in Mycoplasma genitalium among patients with non-gonococcal sexually transmitted infections in Smolensk and Tula

Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study "MARATHON 2015–2016"

Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study "MARATHON 2015–2016"

Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study "MARATHON 2015–2016"

Antimicrobial Resistance of Nosocomial Acinetobacter spp. Isolates in Russia: Results of National Multicenter Surveillance Study "MARATHON" 2011–2012

Antimicrobial Resistance of Nosocomial Pseudomonas aeruginosa Isolates in Russia: Results of National Multicenter Surveillance Study "MARATHON" 2011–2012

Antimicrobial Resistance of Nosocomial Staphylococcus aureus Isolates in Russia: Results of National Multicenter Surveillance Study "MARATHON" 2011–2012

Antimicrobial Resistance of Nosocomial Enterobacteriaceae Isolates in Russia: Results of National Multicenter Surveillance Study "MARATHON" 2011–2012

Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015)

Support and Sponsors

The development and administration of AMRmap web platform are supported by the Inter-regional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) and Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU).
The surveillance programs are supported by a group of pharmaceutical companies listed below:
Company Seasons
logo 2016-2020
logo 2018-2019
logo 2016-2020
logo 2018
logo 2016
IAC IACMAC
Mail to Facebook VK Twitter Instagram